⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethoxymethane SCHEMBL1781258 | 0.73 | — | — | |
| Methoxymethane SCHEMBL8752418 | 0.72 | — | — | |
| Dimethoxymethane SCHEMBL4642 | 0.71 | — | — | |
| Dimethoxymethane SCHEMBL474301 | 0.71 | — | — | |
| Dimethoxymethane SCHEMBL8330941 | 0.71 | — | — | |
| SCHEMBL14303316 | 0.70 | — | — | |
| Dimethoxymethane SCHEMBL7997400 | 0.70 | — | — | |
| SCHEMBL12336956 | 0.69 | — | — | |
| SCHEMBL17071802 | 0.69 | — | — | |
| Dimethoxymethane SCHEMBL8038633 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843876-A | New anti-malarial agents | MMV疟疾药物投资公司 | 2019-06-04 | — | — | CN | claimed |
| CN-101842377-B | Dispiro 1,2,4-trioxolane antimalarials | MEDICINES MALARIA VENTURE MMV | 2015-07-01 | — | — | CN | claimed |
| US-20230265503-A1 | CYCLOOCTATETRAENE CONTAINING DYES AND COMPOSITIONS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-08-24 | — | — | US | disclosed |
| CN-106459079-B | The medical application of artemisinin compounds and pontin protein agonist | 分子医学研究中心责任有限公司 | 2019-09-24 | — | — | CN | disclosed |
| US-9631194-B2 | Methods and compositions for use in treatment of FOXP2-related cancers | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2017-04-25 | — | — | US | disclosed |
| CN-106459079-A | Medical use of artemisinin compounds and gephyrin agonists | 分子医学研究中心责任有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-102690183-B | From unsaturated fatty acid derivative synthesis alpha, omega-dicarboxylic acid and ester thereof | EVONIK DEGUSSA GMBH (DE) | 2015-11-04 | — | — | CN | disclosed |
| CN-103497237-B | The alpha-MSH analogue of therapeutic activity | ABBVIE INC. (US) | 2015-10-28 | — | — | CN | disclosed |
| CN-101842377-B | Dispiro 1,2,4-trioxolane antimalarials | MEDICINES MALARIA VENTURE MMV | 2015-07-01 | — | — | CN | disclosed |
| CN-101490032-B | A process for the preparation of spiro and dispiro 1,2,4-trioxolane antimalarials (oz277) | RANBAXY LAB LTD | 2014-12-17 | — | — | CN | disclosed |
| CN-102112467-B | Pyrimidine derivative as kinase inhibitors | IRM LLC | 2014-04-30 | — | — | CN | disclosed |
| EP-0068840-B1 | MANUFACTURE OF AQUEOUS FORMALDEHYDE | MONSANTO COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
| EP-0079322-B1 | MANUFACTURE OF AQUEOUS FORMALDEHYDE | MONSANTO COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
| US-4454354-A | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0100809-A1 | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1984-02-22 | — | — | EP | disclosed |
| US-4385188-A | Process for removing methanol from aqueous formaldehyde | MONSANTO COMPANY (US) | 1983-05-24 | — | — | US | disclosed |
| EP-0079322-A1 | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1983-05-18 | — | — | EP | disclosed |
| US-4383123-A | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1983-05-10 | — | — | US | disclosed |
| EP-0068840-A1 | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |
| US-4348540-A | Manufacture of aqueous formaldehyde | MONSANTO COMPANY (US) | 1982-09-07 | — | — | US | disclosed |